Skip to content
10-Q

Quarterly Report

Amneal Pharmaceuticals, Inc. AMRX

0001723128-25-000062

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 314.36M sh
Shares Diluted Q3 2025 · Sep 30, 2025 324.75M sh
Shares Diluted Q3 2025 · Sep 30, 2025 323.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 309.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 308.69M sh
Capex Q3 2025 · Sep 30, 2025 $48.29M
Capex Q3 2025 · Sep 30, 2024 $36.77M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $209.68M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $177.02M
Long Term Debt Q3 2025 · Sep 30, 2025 $2.57B
Long Term Debt Q3 2025 · Dec 31, 2024 $2.16B
Short Term Debt Q3 2025 · Sep 30, 2025 $7.2M
Short Term Debt Q3 2025 · Dec 31, 2024 $224.21M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $201.25M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $110.55M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $74.01M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$109.46M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$109.27M
Current Liabilities Q3 2025 · Sep 30, 2025 $862.11M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.13B
Current Assets Q3 2025 · Sep 30, 2025 $1.84B
Current Assets Q3 2025 · Dec 31, 2024 $1.59B
Total Assets Q3 2025 · Sep 30, 2025 $3.6B
Total Assets Q3 2025 · Dec 31, 2024 $3.5B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.01
Eps Diluted Q3 2025 · Sep 30, 2025 $0.11
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.28
Eps Basic Q3 2025 · Sep 30, 2025 $0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.12
Eps Basic Q3 2025 · Sep 30, 2024 $0.00
Eps Basic Q3 2025 · Sep 30, 2024 −$0.28
Sga Expense Q3 2025 · Sep 30, 2025 $137.82M
Sga Expense Q3 2025 · Sep 30, 2025 $380.37M
Sga Expense Q3 2025 · Sep 30, 2024 $118.69M
Sga Expense Q3 2025 · Sep 30, 2024 $347.75M
Rd Expense Q3 2025 · Sep 30, 2025 $63.35M
Rd Expense Q3 2025 · Sep 30, 2025 $151.36M
Rd Expense Q3 2025 · Sep 30, 2024 $61.1M
Rd Expense Q3 2025 · Sep 30, 2024 $136.45M
Net Income Q3 2025 · Sep 30, 2025 $2.37M
Net Income Q3 2025 · Sep 30, 2025 $36.98M
Net Income Q3 2025 · Sep 30, 2024 −$156K
Net Income Q3 2025 · Sep 30, 2024 −$85.81M
Operating Income Q3 2025 · Sep 30, 2025 $70.34M
Operating Income Q3 2025 · Sep 30, 2025 $282.06M
Operating Income Q3 2025 · Sep 30, 2024 $88.81M
Operating Income Q3 2025 · Sep 30, 2024 $173.53M
Gross Profit Q3 2025 · Sep 30, 2025 $273.97M
Gross Profit Q3 2025 · Sep 30, 2025 $816.12M
Gross Profit Q3 2025 · Sep 30, 2024 $269.56M
Gross Profit Q3 2025 · Sep 30, 2024 $757.57M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $510.54M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.39B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $432.91M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.31B
Revenue Q3 2025 · Sep 30, 2025 $784.51M
Revenue Q3 2025 · Sep 30, 2025 $2.2B
Revenue Q3 2025 · Sep 30, 2024 $702.47M
Revenue Q3 2025 · Sep 30, 2024 $2.06B